161 related articles for article (PubMed ID: 37524283)
1. Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer.
Kumar K; Rawat SG; Manjit ; Mishra M; Priya ; Kumar A; Chawla R
Int J Biol Macromol; 2023 Sep; 249():126057. PubMed ID: 37524283
[TBL] [Abstract][Full Text] [Related]
2. Chitosan cross-linked docetaxel loaded EGF receptor targeted nanoparticles for lung cancer cells.
Maya S; Sarmento B; Lakshmanan VK; Menon D; Seabra V; Jayakumar R
Int J Biol Macromol; 2014 Aug; 69():532-41. PubMed ID: 24950310
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.
Sreeranganathan M; Uthaman S; Sarmento B; Mohan CG; Park IK; Jayakumar R
Int J Nanomedicine; 2017; 12():7165-7182. PubMed ID: 29033568
[TBL] [Abstract][Full Text] [Related]
4. Sialic Acid Conjugated Chitosan Nanoparticles: Modulation to Target Tumour Cells and Therapeutic Opportunities.
Rana R; Rani S; Kumar V; Nakhate KT; Ajazuddin ; Gupta U
AAPS PharmSciTech; 2021 Dec; 23(1):10. PubMed ID: 34862568
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Cancer Microenvironment Responsive Glycan Receptor-Targeted Nanoparticles for Gemcitabine Delivery to Benzo[a]pyrene-Induced Lung Cancer Model.
Kumar K; Verma R; Manjit ; Priya ; Mishra M; Rani V; Chawla R
AAPS PharmSciTech; 2023 Dec; 25(1):2. PubMed ID: 38114772
[TBL] [Abstract][Full Text] [Related]
6. Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer.
Kumari L; Ehsan I; Mondal A; Al Hoque A; Mukherjee B; Choudhury P; Sengupta A; Sen R; Ghosh P
J Drug Target; 2023 Jun; 31(5):521-536. PubMed ID: 37010248
[TBL] [Abstract][Full Text] [Related]
7. Formulation and
Viswanadh MK; Vikas ; Jha A; Reddy Adena SK; Mehata AK; Priya V; Neogi K; Poddar S; Mahto SK; Muthu MS
Nanomedicine (Lond); 2020 Oct; 15(24):2345-2367. PubMed ID: 32945225
[No Abstract] [Full Text] [Related]
8. EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy.
Ye Z; Zhang Y; Liu Y; Liu Y; Tu J; Shen Y
Int J Nanomedicine; 2021; 16():2443-2459. PubMed ID: 33814909
[TBL] [Abstract][Full Text] [Related]
9. Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells.
Maya S; Sarmento B; Lakshmanan VK; Menon D; Jayakumar R
J Biomed Nanotechnol; 2014 Aug; 10(8):1416-28. PubMed ID: 25016642
[TBL] [Abstract][Full Text] [Related]
10. Molecularly targeted gemcitabine-loaded nanoparticulate system towards the treatment of EGFR overexpressing lung cancer.
Wang XB; Zhou HY
Biomed Pharmacother; 2015 Mar; 70():123-8. PubMed ID: 25776490
[TBL] [Abstract][Full Text] [Related]
11. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery.
Bhattacharya S; Anjum MM; Patel KK
Drug Deliv; 2022 Dec; 29(1):1060-1074. PubMed ID: 35363113
[TBL] [Abstract][Full Text] [Related]
13. Near-infrared/pH dual-responsive nanocomplexes for targeted imaging and chemo/gene/photothermal tri-therapies of non-small cell lung cancer.
Li Z; Zhu L; Liu W; Zheng Y; Li X; Ye J; Li B; Chen H; Gao Y
Acta Biomater; 2020 Apr; 107():242-259. PubMed ID: 32151700
[TBL] [Abstract][Full Text] [Related]
14. EGFR Targeted Redox Sensitive Chitosan Nanoparticles of Cabazitaxel: Dual-Targeted Cancer Therapy, Lung Distribution, and Targeting Studies by Photoacoustic and Optical Imaging.
Vikas ; Mehata AK; Viswanadh MK; Malik AK; Setia A; Kumari P; Mahto SK; Muthu MS
Biomacromolecules; 2023 Nov; 24(11):4989-5003. PubMed ID: 37871263
[TBL] [Abstract][Full Text] [Related]
15. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
Eivazi N; Rahmani R; Paknejad M
Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
[TBL] [Abstract][Full Text] [Related]
16. EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity.
Sandoval MA; Sloat BR; Lansakara-P DS; Kumar A; Rodriguez BL; Kiguchi K; Digiovanni J; Cui Z
J Control Release; 2012 Jan; 157(2):287-96. PubMed ID: 21871505
[TBL] [Abstract][Full Text] [Related]
17. Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer.
Kim YJ; Baek DS; Lee S; Park D; Kang HN; Cho BC; Kim YS
Cancer Lett; 2019 Dec; 466():23-34. PubMed ID: 31521695
[TBL] [Abstract][Full Text] [Related]
18. Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.
Chen G; Kronenberger P; Teugels E; Umelo IA; De Grève J
BMC Med; 2012 Mar; 10():28. PubMed ID: 22436374
[TBL] [Abstract][Full Text] [Related]
19. Mad2 checkpoint gene silencing using epidermal growth factor receptor-targeted chitosan nanoparticles in non-small cell lung cancer model.
Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
Mol Pharm; 2014 Oct; 11(10):3515-27. PubMed ID: 25256346
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells.
Patel J; Amrutiya J; Bhatt P; Javia A; Jain M; Misra A
J Microencapsul; 2018 Mar; 35(2):204-217. PubMed ID: 29542378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
